|
Evaluating Patient Participation in Phase I Clinical Trials Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Evaluating Patient Participation in Phase I Clinical Trials conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Evaluating Patient Participation in Phase I Clinical Trials Clinical research trials and Evaluating Patient Participation in Phase I Clinical Trials medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Evaluating Patient Participation in Phase I Clinical Trials. Evaluating Patient Participation in Phase I Clinical Trials Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Evaluating Patient Participation in Phase I Clinical Trials clinical trial. Participants frequently obtain the most expert healthcare available for their Evaluating Patient Participation in Phase I Clinical Trials condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluating Patient Participation in Phase I Clinical Trials  Evaluating Patient Participation in Phase I Clinical Trials
Evaluating Patient Participation in Phase I Clinical Trials
For Condition: unspecified adult solid tumor, protocol specific,psychosocial effects/treatment
Status: Recruiting
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: RATIONALE: Evaluating patient participation in clinical trials may help improve treatments for cancer. PURPOSE: Clinical trial to determine the reasons for participation, perceptions, and expectations of patients receiving treatment for cancer in phase I clinical trials.
Details: OBJECTIVES: - Describe the motivations, perceptions, and expectations of patients enrolled in a phase I clinical trial. - Assess the influence of age, education, and gender upon the perception of these patients. - Compare the difference in perceptions, motivations, and expectations of patients who have previously participated in a phase I clinical trial vs those who have not. - Determine whether patients' perceptions, motivations, and expectations change while enrolled in a phase I clinical trial. - Validate an interviewer-administered tool measuring the perceptions, motivations, and expectations of these patients. - Assess patients' perception of the information they were given while enrolled in a phase I clinical trial. OUTLINE: Patients are interviewed over the phone to evaluate their perceptions, motivations, and expectations of phase I clinical trials. Patients complete a questionnaire comprising 24 questions over 30-45 minutes. Interviews are conducted within 1 week after enrolling in a phase I clinical trial (prior to the first dose of study agent) and then again 2 months later (or at the time the patient stops treatment). The first 10 patients enrolled complete an additional 6 questions over 15 minutes during the first interview to validate the questionnaire, but do not complete a second interview. PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study within 1 year.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Enrolled in a phase I clinical trial within the past week - Signed an informed consent for a phase I trial PATIENT CHARACTERISTICS: Age - 18 and over Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified Other - Able to follow basic verbal instructions as witnessed by the investigator or a representative - Able to understand and speak English as determined by the investigator or a representative - Access to a telephone PRIOR CONCURRENT THERAPY: Biologic therapy - Not specified Chemotherapy - Not specified Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Not specified Other - Prior participation in a phase I clinical trial allowed
Total Enrollment:
Location and Contact Information:
Overall Study Official:
DonnaHeadlee, Study Chair, National Cancer Institute (NCI)
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support *Recruiting*
Bethesda, Maryland, 20892-1182
United States
Recruiting Patient Recruitment 1-888-NCI-1937
Additional Information:
Study ID Numbers: CDR0000069497; NCI-02-C-0204
Study Start Date:
Record last reviewed: December 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043030
Other Unspecified Adult Solid Tumor, Protocol Specific Studies:
1. Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
2. Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer
3. Study of Decision Making in Patients Participating in Phase I Clinical Trials
4. Video Support Program For Families With a Parent Newly Diagnosed With Cancer
5. Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Related Studies:
Other unspecified adult solid tumor, protocol specific Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluating Patient Participation in Phase I Clinical Trials
|
|
|
|
|
|
|
|
